Macrocyclic Peptide Modulators of Protein Function
Macrocyclic Peptide Modulators of Protein Function
批准号:
10000964
负责人:
Rudi Fasan
金额:
$28.41万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-01 至 2023-08-31
关键词:
AddressAffinityAmino Acyl-tRNA SynthetasesBacteriophage M13BindingBiologyBiomedical ResearchCell physiologyCellsChemical AgentsChemicalsCyclic PeptidesCyclizationDetectionDevelopmentDiseaseDoctor of PhilosophyEffectivenessEnzymesEukaryotic CellGenerationsGeneticGuidelinesHumanHybridsInvestigationLabelLeadLibrariesLigandsMammalian CellMediatingMembrane ProteinsMethodologyMethodsMolecularMolecular ConformationNatural ProductsPD-1 inhibitorsPD-1/PD-L1Pathway interactionsPeptide SynthesisPeptidesPhage DisplayPharmaceutical PreparationsPhenotypeProcessProteinsReagentRecombinantsResearchRoleSignal PathwaySignaling ProteinSonicationSourceSpecificityStructureSystemTechnologyTherapeuticYeastsanalogbasedrug developmentdrug discoverydrug structureinhibitor/antagonistinnovationpolypeptideprotein functionprotein phosphatase inhibitor-2protein protein interactionscaffoldscreeningsmall moleculesmoothened signaling pathwaytherapeutic developmenttherapeutic targettoolunnatural amino acidsyeast two hybrid system
中文摘要
蛋白质功能的大环肽调节剂
蛋白质介导的相互作用在细胞生理和疾病中的研究进展
严重依赖于能够靶向和调节蛋白质功能的化学试剂的可用性
高效、高选择性。虽然小分子试剂提供了化学探针和
治疗,压倒性的人类蛋白质和蛋白质介导的相互作用仍然是不可渗透的
利用这类分子进行调制,这对旨在阐明它们的
在生理病理过程中的作用和评估其治疗潜力。我们小组最近介绍了
一种高效和高度通用的产生小尺寸、遗传编码大环肽的方法
并证明了这些类似天然产物的化合物能够有效地破坏一种
挑战高效和特异性的蛋白质-蛋白质相互作用。在这个项目中,这个通用的方法
对于大环肽合成,将依次与噬菌体展示和基于细胞的选择系统集成
实施功能强大的高通量平台,以快速发现有效和选择性的大环
蛋白质的多肽调节剂和蛋白质之间的相互作用。这项研究的成功完成是
期望使新的、高效的和易于访问的技术对开发有用
高效、选择性调节蛋白质功能的大环肽类药物
在广泛的目标蛋白质和细胞过程中。因此,这些技术必然会
简化用于询问细胞途径和验证治疗效果的化学探针的开发
靶标,蛋白质检测和标记的选择性试剂的产生,以及潜在的识别
领导药物开发机构,从而加快基础生物医学研究、化学
生物学和药物发现。
英文摘要
Macrocyclic Peptide Modulators of Protein Function
Progress toward an understanding of protein-mediated interactions involved in cell physiology and disease
heavily relies on the availability of chemical agents capable of targeting and modulating protein function with
high potency and selectivity. While small-molecule agents have provided a major source of chemical probes and
therapeutics, an overwhelming fraction of human proteins and protein-mediated interactions remains impervious
to modulation using this class of molecules, posing a fundamental barrier to efforts directed at elucidating their
role in physiopathological processes and assessing their therapeutic potential. Our group has recently introduced
an efficient and highly versatile methodology for generating small-size, genetically encoded macrocyclic peptides
in living cells and demonstrated the effectiveness of these 'natural product-like' compounds to disrupt a
challenging protein-protein interaction with high potency and specificity. In this project, this versatile methodology
for macrocyclic peptide synthesis will be integrated with phage display and cell-based selection systems in order
to implement powerful, high-throughput platforms for the rapid discovery of potent and selective macrocyclic
peptide modulators of proteins and protein-protein interactions. Successful completion of this research is
expected to make available new, efficient, and readily accessible technologies useful for developing
macrocyclic peptide agents capable of modulating protein function with high potency and selectivity
across a wide range of target proteins and cellular processes. As such, these technologies are bound to
streamline the development of chemical probes for interrogating cellular pathways and validating therapeutic
targets, the generation of selective reagents for protein detection and labeling, and the identification of potential
lead structures for drug development, thereby accelerating efforts in basic biomedical research, chemical
biology, and drug discovery.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing Cyclopeptide Nef Inhibitors to Facilitate HIV-1 Eradication
-
批准号:10759561
-
项目类别:
-
资助金额:$70.18万
-
财政年份:2023
-
负责人:Rudi Fasan
-
依托单位:
Developing Cyclopeptide Nef Inhibitors to Facilitate HIV-1 Eradication
-
批准号:10652729
-
项目类别:
-
资助金额:$53.86万
-
财政年份:2022
-
负责人:Rudi Fasan
-
依托单位:
Macrocyclic Peptide Modulators of Protein Function
-
批准号:10470247
-
项目类别:
-
资助金额:$13.38万
-
财政年份:2019
-
负责人:Rudi Fasan
-
依托单位:
Macrocyclic inhibitors of upstream protein activators of the Hedgehog pathway
-
批准号:8895869
-
项目类别:
-
资助金额:$20.03万
-
财政年份:2014
-
负责人:Rudi Fasan
-
依托单位:
Macrocyclic inhibitors of upstream protein activators of the Hedgehog pathway
-
批准号:8755152
-
项目类别:
-
资助金额:$16.69万
-
财政年份:2014
-
负责人:Rudi Fasan
-
依托单位:
Selective P450 Oxidation Catalysts for Synthesis of Bioactive Molecules
-
批准号:8472499
-
项目类别:
-
资助金额:$26.09万
-
财政年份:2012
-
负责人:Rudi Fasan
-
依托单位:
Metalloprotein Catalysts for Asymmetric Synthesis
-
批准号:9896830
-
项目类别:
-
资助金额:$35.89万
-
财政年份:2012
-
负责人:Rudi Fasan
-
依托单位:
Metalloprotein catalysts for asymmetric synthesis
-
批准号:10210696
-
项目类别:
-
资助金额:$40.94万
-
财政年份:2012
-
负责人:Rudi Fasan
-
依托单位:
Selective P450 Oxidation Catalysts for Synthesis of Bioactive Molecules
-
批准号:9272479
-
项目类别:
-
资助金额:$5.52万
-
财政年份:2012
-
负责人:Rudi Fasan
-
依托单位:
Acquisition of Supercritical Fluid Chromatography System
-
批准号:10797957
-
项目类别:
-
资助金额:$11.56万
-
财政年份:2012
-
负责人:Rudi Fasan
-
依托单位:
Selective P450 Oxidation Catalysts for Synthesis of Bioactive Molecules
-
批准号:8643262
-
项目类别:
-
资助金额:$27.04万
-
财政年份:2012
-
负责人:Rudi Fasan
-
依托单位:
Selective P450 Oxidation Catalysts for Synthesis of Bioactive Molecules
-
批准号:8273019
-
项目类别:
-
资助金额:$27.04万
-
财政年份:2012
-
负责人:Rudi Fasan
-
依托单位:
Metalloprotein catalysts for asymmetric synthesis
-
批准号:10596493
-
项目类别:
-
资助金额:$38.34万
-
财政年份:2012
-
负责人:Rudi Fasan
-
依托单位:
Metalloprotein Catalysts for Asymmetric Synthesis
-
批准号:9383171
-
项目类别:
-
资助金额:$38.68万
-
财政年份:2012
-
负责人:Rudi Fasan
-
依托单位:
Metalloprotein catalysts for asymmetric synthesis
-
批准号:10382445
-
项目类别:
-
资助金额:$38.96万
-
财政年份:2012
-
负责人:Rudi Fasan
-
依托单位:
海外基金